KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fulgent Genetics (FLGT) Treasury Shares (2016 - 2025)

Fulgent Genetics' Treasury Shares history spans 10 years, with the latest figure at $600000.0 for Q4 2025.

  • For Q4 2025, Treasury Shares rose 5900.0% year-over-year to $600000.0; the TTM value through Dec 2025 reached $600000.0, up 5900.0%, while the annual FY2025 figure was $600000.0, 5900.0% up from the prior year.
  • Treasury Shares for Q4 2025 was $600000.0 at Fulgent Genetics, up from $177000.0 in the prior quarter.
  • Across five years, Treasury Shares topped out at $2.6 million in Q4 2022 and bottomed at $10000.0 in Q1 2024.
  • The 5-year median for Treasury Shares is $342000.0 (2022), against an average of $651333.3.
  • The largest annual shift saw Treasury Shares crashed 99.0% in 2024 before it skyrocketed 5900.0% in 2025.
  • A 5-year view of Treasury Shares shows it stood at $1.6 million in 2021, then soared by 62.51% to $2.6 million in 2022, then tumbled by 61.99% to $1.0 million in 2023, then plummeted by 99.0% to $10000.0 in 2024, then surged by 5900.0% to $600000.0 in 2025.
  • Per Business Quant, the three most recent readings for FLGT's Treasury Shares are $600000.0 (Q4 2025), $177000.0 (Q2 2025), and $469000.0 (Q1 2025).